Atom Investors LP Increases Stake in ARK Genomic Revolution ETF (BATS:ARKG)

Atom Investors LP boosted its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 15.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 49,131 shares of the company’s stock after purchasing an additional 6,496 shares during the period. Atom Investors LP owned approximately 0.09% of ARK Genomic Revolution ETF worth $1,258,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. EverSource Wealth Advisors LLC purchased a new stake in shares of ARK Genomic Revolution ETF in the 1st quarter valued at $49,000. Cetera Investment Advisers grew its position in ARK Genomic Revolution ETF by 290.7% during the 1st quarter. Cetera Investment Advisers now owns 140,897 shares of the company’s stock worth $4,052,000 after purchasing an additional 104,831 shares during the period. CWM LLC raised its stake in shares of ARK Genomic Revolution ETF by 7.7% during the 2nd quarter. CWM LLC now owns 48,260 shares of the company’s stock valued at $1,133,000 after buying an additional 3,432 shares during the last quarter. SG Americas Securities LLC lifted its holdings in shares of ARK Genomic Revolution ETF by 5.4% in the 2nd quarter. SG Americas Securities LLC now owns 129,356 shares of the company’s stock valued at $3,037,000 after buying an additional 6,675 shares during the period. Finally, Wealth Enhancement Advisory Services LLC lifted its holdings in shares of ARK Genomic Revolution ETF by 10.7% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 44,424 shares of the company’s stock valued at $1,043,000 after buying an additional 4,305 shares during the period.

ARK Genomic Revolution ETF Trading Down 3.7 %

ARK Genomic Revolution ETF stock opened at $25.70 on Wednesday. The business’s 50 day moving average is $24.62 and its 200-day moving average is $25.10.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.